Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4c4h.1

Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.80 Å
Oligo State
monomer
Ligands
1 x 7RO: tert-butyl 6-((2-chloro-4-(dimethylcarbamoyl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate(Non-covalent)
1 x 7PE: 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Naud, S. et al., Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3, 2-C]Pyridine Inhibitors of the Mitotic Kinase Monopolar Spindle 1 (Mps1). J.Med.Chem. (2013)
Release Date
2013-12-04
Peptides
DUAL SPECIFICITY PROTEIN KINASE TTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

DUAL SPECIFICITY PROTEIN KINASE TTK

Related Entries With Identical Sequence

3cek.1 | 3cek.2 | 3gfw.1 | 3h9f.1 | 3h9f.2 | 4bhz.1 | 4bi0.1 | 4bi1.1 | 4bi2.1 | 4c4e.1 | 4c4f.1 | 4c4g.1 | 4c4i.1 | 4c4j.1 | 4cv8.1 | 4cv9.1 | 4cva.1 | 5ap0.1 | 5ap1.1 | 5ap2.1 | 5ehl.1 | 5eho.1 | 5ehy.1 | 5ei2.1 | 5ei6.1 | 5ei8.1 | 5n87.1 | 7lqd.1 | 7lqd.2